Atrial fibrillation, cognitive impairment, frailty and disability in older heart failure patients

Journal of Cardiovascular Medicine

Volumn 17, Issue 8, 2016, Pages 616-623

  Pulignano, Giovanni ^a   Del Sindaco, Donatella ^b   Tinti, Maria D ^a   Di Lenarda, Andrea ^c   Alunni, Gianfranco ^d   Senni, Michele ^e   Tarantini, Luigi ^f   Cioffi, Giovanni ^g   Barbati, Giulia ^c   Minardi, Giovanni ^a   Murrone, Adriano ^d   Ciurluini, Paola ^a   Uguccioni, Massimo ^a  

^a SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^b NUOVO REGINA MARGHERITA HOSPITAL   (Italy)

^c Cardiovascular Center   (Italy)

^d SANTA MARIA DELLA MISERICORDIA HOSPITAL   (Italy)

^e PAPA GIOVANNI XXIII HOSPITAL   (Italy)

^f SAN MARTINO HOSPITAL   (Italy)

^g Villa Bianca Hospital   (Italy)

Author keywords

Atrial fibrillation; cognitive impairment; disability; elderly; frailty; gait speed; heart failure

Indexed keywords

ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

AGED; ARTICLE; ATRIAL FIBRILLATION; CARDIOVASCULAR MORTALITY; COGNITIVE DEFECT; CORONARY CARE UNIT; DAILY LIFE ACTIVITY; DISABILITY; DISEASE ASSOCIATION; FEMALE; FRAIL ELDERLY; GAIT; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MALE; MEDICAL HISTORY; MINI MENTAL STATE EXAMINATION; MORBIDITY; PAROXYSMAL ATRIAL FIBRILLATION; PERSISTENT ATRIAL FIBRILLATION; VALVULAR HEART DISEASE; WALKING SPEED; CHRONIC DISEASE; CLINICAL TRIAL; COGNITIVE DYSFUNCTION; COMPLICATION; HEART LEFT VENTRICLE FUNCTION; KAPLAN MEIER METHOD; LONGITUDINAL STUDY; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGICAL RATING SCALE; STATISTICAL MODEL; VERY ELDERLY;

ACTIVITIES OF DAILY LIVING; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; CHRONIC DISEASE; COGNITIVE DYSFUNCTION; FEMALE; FRAIL ELDERLY; GAIT; HEART FAILURE; HUMANS; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; MULTIVARIATE ANALYSIS; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; VENTRICULAR FUNCTION, LEFT;

EID: 84958787011     PISSN: 15582027     EISSN: 15582035     Source Type: Journal    
DOI: 10.2459/JCM.0000000000000366     Document Type: Article

References (53)

1. Ho KK, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: the Framingham Study. J Am Coll of Cardiol 1993; 22(4 Suppl A):6A-13A.
2. Senni M, Tribouilloy CM, Rodeheffer RJ, et al. Congestive heart failure in the community: trends in incidence and survival in a 10-year period. Arch Intern Med 1999; 159:29-34.
3. Anter E, Jessup M, Callans DJ. Atrial fibrillation and heart failure: treatment considerations for a dual epidemic. Circulation 2009; 119:2516-2525.
4. Mamas MA, Caldwell JC, Chacko S, et al. A meta-analysis of the prognostic significance of atrial fibrillation in chronic heart failure. Eur J Heart Fail 2009; 11:676-683.
5. Vogels RLC, Scheltens P, Schroeder-Tanka JM, Weinstein HC. Cognitive impairment in heart failure: a systematic review of the literature. Eur J Heart Fail 2007; 9:440-449.
6. Cacciatore F, Abete P, Ferrara N, et al. Congestive heart failure and cognitive impairment in an older population. J Am Geriatr Soc 1998; 46:1343-1348.
7. Zuccalà G, Pedone C, Cesari M, et al. The effects of cognitive impairment on mortality among hospitalized patients with heart failure. Am J Med 2003; 115:97-103.
8. Pressler SJ, Kim J, Riley P, et al. Memory dysfunction, psychomotor slowing, and decreased executive function predict mortality in patients with heart failure and low ejection fraction. J Card Fail 2010; 16:750-760.
9. Kalantarian S, Stern TA, Mansour M, Ruskin JN. Cognitive impairment associated with atrial fibrillation: a meta-analysis. Ann Intern Med 2013; 158 (5 Pt 1):338-346.
10. Thacker E, McKnight B, Psaty BM, et al. Atrial fibrillation and cognitive decline. A longitudinal cohort study. Neurology 2013; 81:119-125.
11. Udompanich S, Lip GY, Apostolakis S, et al. Atrial fibrillation as a risk factor for cognitive impairment: a semi-systematic review. Q J Med 2013; 106:795-802.
12. Lavy S, Stern S, Melamed E, et al. Effect of chronic atrial fibrillation on regional cerebral blood flow. Stroke 1980; 11:35-38.
13. Hui DS, Morley JE, Mikolajczak PC, Lee R. Atrial fibrillation: a major risk factor for cognitive decline. Am Heart J 2015; 169:448-456.
14. Afilalo J, Alexander KP, Mack MJ, et al. Frailty assessment in the cardiovascular care of older adults. J Am Coll Cardiol 2014; 63:747-762.
15. Dumurgier J, Elbaz A, Ducimetiè re P, et al. Slow walking speed and cardiovascular death in well functioning older adults: prospective cohort study. BMJ 2009; 339:b4460.
16. Cesari M, Kritchevsky SB, Penninx BW, et al. Prognostic value of usual gait speed in well functioning older people. J Am Geriatr Soc 2005; 53:1675-1680.
17. Robertson DA, Savvaa GM, Kennya RA. Frailty and cognitive impairment. A review of the evidence and causal mechanisms. Ageing Res Rev 2013; 12:840-851.
18. Pulignano G, Del Sindaco D, Di Lenarda A, Sinagra G. The evolving care of the elderly with heart failure: from the 'high-tech' to the 'high-touch' approach. J Cardiovasc Med (Hagerstown) 2006; 7:841-846.
19. Dickson VA, Tkas N, Riegel B. Cognitive influences on self-care decision making in persons with heart failure. Am Heart J 2008; 154:424-431.
20. McMurray JJ, Adamopoulos S, Anker SD, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 2012; 33:1787-1847.
21. Levey AS, Stevens LA, Schmid CH, et al., CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150:604-612.
22. Gage BF, Waterman AD, Shannon W, et al. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. J Am Med Assoc 2001; 285:2864-2870.
23. Katz S, Ford AB, Moskowitz RW, et al. Studies of illness in the aged: the index of ADL: a standardized measure of biological and psychosocial function. J Am Med Assoc 1963; 185:914-919.
24. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969; 9:179-186.
25. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-198.
26. Sheikh JI, Yesavage JA. Geriatric Depression Scale (GDS): recent evidence and development of a shorter version. In: Brink TL, editor. Clinical gerontology: a guide to assessment and intervention. New York, NY: Haworth Press; 1986. pp. 165-173.
27. Studenski S, Perera S, Wallace D, et al. Physical performance measures in the clinical setting. J Am Geriatr Soc 2003; 51:314-322.
28. Bunch TJ, Weiss JP, Crandall BG, et al. Atrial fibrillation is independently associated with senile, vascular, and Alzheimer's dementia. Heart Rhythm 2010; 7:433-437.
29. Rich MW. Heart failure in the oldest patients: the impact of comorbid conditions. Am J Geriatr Cardiol 2005; 14:134-141.
30. Aronow WS. Management of the older person with atrial fibrillation. J Gerontol A Biol Sci Med Sci 2002; 57:M352-M363.
31. Chatap G, Giraud K, Vincent JP. Atrial fibrillation in the elderly: facts and management. Drugs Aging 2002; 19:819-846.
32. Abete P, Della-Morte D, Gargiulo G, et al. Cognitive impairment and cardiovascular diseases in the elderly. A heart-brain continuum hypothesis. Ageing Res Rev 2014; 18:41-52.
33. O'Connell JE, Gray CS, French JM, Robertson IH. Atrial fibrillation and cognitive function: case-control study. J Neurol Neurosurg Psychiatry 1998; 65:386-389.
34. Gibbs CR, Blann AD, Watson RDS, Lip GYH. Abnormalities of hemorheological, endothelial, and platelet function in patients with chronic heart failure in sinus rhythm: effects of angiotensin-converting enzyme inhibitor and beta-blocker therapy. Circulation 2001; 103:1746-1751.
35. Kwok CS, Loke YK, Hale R, et al. Atrial fibrillation and incidence of dementia: a systematic review and meta-analysis. Neurology 2011; 76:914-922.
36. Georgiadis D, Sievert M, Cencetti S, et al. Cerebrovascular reactivity is impaired in patients with cardiac failure. Eur Heart J 2000; 21:407-413.
37. Zuccalà G, Onder G, Pedone C, et al., on behalf of the GIFA-ONLUS Study Group. Hypotension and cognitive impairment: selective association in patients with heart failure. Neurology 2001; 57:1986-1992.
38. Cacciatore F, TestaG, Langellotto A, et al. Role of ventricular rate response on dementia in cognitively impaired elderly subjects with atrial fibrillation: a 10-year study. Dement Geriatr Cogn Disord 2012; 34 (3-4):143-148.
39. Alosco ML, Spitznagel MB, Sweet LH, et al. Atrial fibrillation exacerbates cognitive dysfunction and cerebral perfusion in heart failure. Pacing Clin Electrophysiol 2015; 38:178-186.
40. Annweiler C, Ferland G, Barberger-Gateau P, et al. Vitamin K antagonists and cognitive impairment: results from a cross-sectional pilot study among geriatric patients. J Gerontol A Biol Sci Med Sci 2015; 70:97-101.
41. Stollberger C, Finsterer J. Concerns about the use of new oral anticoagulants for stroke prevention in elderly patients with atrial fibrillation. Drugs Aging 2013; 30:949-958.
42. Marzona I, O'Donnell M, Teo K, et al. Increased risk of cognitive and functional decline in patients with AF: results of the ONTARGET and TRANSCEND studies. CMAJ 2012; 184:329-336.
43. Flaker GC, Pogue J, Yusuf S, et al. Cognitive function and anticoagulation control in patients with atrial fibrillation. Circ Cardiovasc Qual Outcomes 2010; 3:277-283.
44. Khreizat HS, Whittaker P, Curtis KD, et al. The effect of cognitive impairment in the elderly on the initial and long-term stability of warfarin therapy. Drugs Aging 2012; 29:307-317.
45. Maes F, Dalleur O, Henrard S, et al. Risk scores and geriatric profile: can they really help us in anticoagulation decision making among older patients suffering from atrial fibrillation Clin Interv Aging 2014; 9:1091-1099.
46. Lip GY, Laroche C, Dan GA, et al. 'Real-world' antithrombotic treatment in atrial fibrillation: the EORP-AF pilot survey. Am J Med 2014; 127:519-529.
47. De Breucker S, Herzog G, Pepersack T. Could geriatric characteristics explain the under-prescription of anticoagulation therapy for older patients admitted with atrial fibrillation A retrospective observational study. Drugs Aging 2010; 27:807-813.
48. Perera V, Bajorek BV, Matthews S, Hilm SN. The impact of frailty on the utilisation of antithrombotic therapy in older patients with atrial fibrillation. Age Ageing 2009; 38:156-162.
49. Ferrucci L, Bandinelli S, Benvenuti E, et al. Subsystems contributing to the decline in ability to walk: bridging the gap between epidemiology and geriatric practice in the InCHIANTI study. J Am Geriatr Soc 2000; 48:1618-1625.
50. Guralnik JM, Simonsick EM, Ferrucci L, et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol 1994; 49:M85-M94.
51. Visser M, Deeg DJ, Lips P, et al. Skeletal muscle mass and muscle strength in relation to lower-extremity performance in older men and women. J Am Geriatr Soc 2000; 48:381-386.
52. Tombaugh TN, McIntyre NJ. The mini-mental state examination: a comprehensive review. J Am Geriatr Soc 1992; 40:922-935.
53. Nitkunan A, Barrick TR, Charlton RA, et al. Multimodal MRI in cerebral small vessel disease: its relationship with cognition and sensitivity to change over time. Stroke 2008; 39:1999-2005.